Results

Total Results: 674 records

Showing results for "central nervous".

  1. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_Core_Weighted_V2.PDF
    January 01, 2019 - NERVOUS SYSTEM DISORDERS W MCC 28,426 0.08% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 102,794 … SYSTEM W MCC 38,382 0.11% 92: OTHER DISORDERS OF NERVOUS SYSTEM W CC 60,392 0.17% 93: OTHER DISORDERS … OF NERVOUS SYSTEM W/O CC/MCC 29,371 0.08% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 3,924 0.01% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 188,484 0.53% 1: Large Central
  2. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2016_Core.PDF
    January 01, 2016 - NERVOUS SYSTEM DISORDERS W MCC 20,067 0.12% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 80,893 … SYSTEM W MCC 17,899 0.10% 92: OTHER DISORDERS OF NERVOUS SYSTEM W CC 29,049 0.17% 93: OTHER DISORDERS … OF NERVOUS SYSTEM W/O CC/MCC 18,082 0.11% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 1,910 0.01% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 62,141 0.36% 1: Large Central
  3. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2019_CORE_V2.PDF
    January 01, 2019 - SYSTEM NEOPLASMS W MCC 19,991 0.11% 55: NERVOUS SYSTEM NEOPLASMS W/O MCC 7,603 0.04% 56: DEGENERATIVE … NERVOUS SYSTEM DISORDERS W MCC 15,950 0.09% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 55,558 … OF NERVOUS SYSTEM W/O CC/MCC 16,162 0.09% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 2,047 0.01% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 126,995 0.70% 1: Large Central
  4. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2018_Core.PDF
    January 01, 2018 - SYSTEM NEOPLASMS W MCC 20,377 0.12% 55: NERVOUS SYSTEM NEOPLASMS W/O MCC 8,154 0.05% 56: DEGENERATIVE … NERVOUS SYSTEM DISORDERS W MCC 16,700 0.09% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 54,909 … OF NERVOUS SYSTEM W/O CC/MCC 16,141 0.09% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 1,987 0.01% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 108,946 0.62% 1: Large Central
  5. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/49631/psn-pdf
    July 01, 2011 - patient-safety-and-adherence-self-administered-medications The Case A 30-year-old man, with HIV and a recent diagnosis of centralnervous system (CNS) toxoplasmosis, returned to the emergency department (ED) of a community hospital
  6. www.uspreventiveservicestaskforce.org/uspstf/document/final-research-plan18/drug-use-illicit-primary-care-interventions-for-children-and-adolescents-march-2014
    May 15, 2013 - synthetic marijuana * ) Prescription drugs for nonmedical purposes * (opioid pain relievers, centralnervous system depressants, stimulants) Stimulants (cocaine, amphetamine * , methamphetamine
  7. www.ahrq.gov/sites/default/files/wysiwyg/cahps/news-and-events/podcasts/The_Case_for_Improving_Patient_Experience_-2011_10_01_Transcript.pdf
    January 01, 2011 - Larry Morrissey Carla, we felt that giving patients a good experience was really central to the mission … It made people nervous, it made people worry.
  8. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2019_MaskedStats_Core_V2.PDF
    January 01, 2019 - SYSTEM NEOPLASMS W MCC 405 0.01% 55: NERVOUS SYSTEM NEOPLASMS W/O MCC 793 0.03% 56: DEGENERATIVE NERVOUS … SYSTEM DISORDERS W MCC 490 0.02% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 1,635 0.05% 58: … OF NERVOUS SYSTEM W/O CC/MCC 3,442 0.11% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 637 0.02% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 10,767 0.35% 1: Large Central
  9. hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2016_MaskedStats_Core.PDF
    January 01, 2016 - SYSTEM NEOPLASMS W MCC 369 0.01% 55: NERVOUS SYSTEM NEOPLASMS W/O MCC 935 0.03% 56: DEGENERATIVE NERVOUS … SYSTEM DISORDERS W MCC 509 0.02% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 1,540 0.05% 58: … OF NERVOUS SYSTEM W/O CC/MCC 3,513 0.11% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 784 0.03% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 11,886 0.38% 1: Large Central
  10. hcup-us.ahrq.gov/db/nation/nrd/stats/NRD_2014_MaskedStats_Core.PDF
    January 01, 2014 - NERVOUS SYSTEM DISORDERS W MCC 9,133 0.06% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 36,564 … OF NERVOUS SYSTEM W/O CC/MCC 15,033 0.10% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 1,690 0.01% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 62,337 0.42% 1: Large Central … 0.34% 9: Other OR therapeutic nervous system procedures 26,362 0.18% 10: Thyroidectomy; partial or
  11. cds.ahrq.gov/taxonomy/term/57436
    February 26, 2019 - Search All AHRQ Sites Careers Contact Us Español FAQs Email Updates
  12. digital.ahrq.gov/electronic-prescribing-0
    January 01, 2023 - During the 12 months of the study, the alert categories most often triggered were related to risks of centralnervous system side-effects, such as over-sedation (20 percent).
  13. psnet.ahrq.gov/sites/default/files/2020-06/final_june-spotlight_case_slides_06.12.2020.pdf
    January 01, 2020 - class of drugs is frequently associated with errors that can result in adverse events including falls, centralnervous system depression and respiratory depression – Due to their high-risk nature, extra attention
  14. Psn-Pdf (pdf file)

    psnet.ahrq.gov/node/73549/psn-pdf
    July 28, 2021 - Anesthetic Systemic Toxicity (LAST) refers to complications affecting the cardiovascular (CVS) and centralnervous (CNS) symptoms due to local anesthetic overdose.
  15. effectivehealthcare.ahrq.gov/sites/default/files/pdf/lysosomal-storage-diseases-therapies_research-protocol.pdf
    November 15, 2012 - These diseases in general do not have central nervous system manifestations, although this may vary … There can be both central and peripheral nervous system involvement in this form of the disease, but
  16. hcup-us.ahrq.gov/reports/statbriefs/sb157.pdf
    March 01, 2013 - poisoning (combined) and respiratory disorders were the most common reasons for all ED visits, followed by nervous … conditions Skin and subcutaneous tissue disorders Digestive disorders Infectious and parasitic diseases Nervous … classification scheme for U.S. counties developed by the National Center for Health Statistics (NCHS): – Large Central … Metropolitan: Central counties of metropolitan areas with 1 million or more residents – Large Fringe
  17. hcup-us.ahrq.gov/db/nation/nis/tools/stats/NIS_2010_MaskedStats_Severity.PDF
    January 01, 2010 - system & related procedures 5,477 0.07% 40: Spinal disorders & injuries 1,897 0.02% 41: Nervous system … malignancy 10,086 0.13% 42: Degenerative nervous system disorders exc mult sclerosis 21,663 0.28% … system 3,125 0.04% 50: Non-bacterial infections of nervous system exc viral meningitis 3,615 0.05% … nos,uncomplicated intracranial injury, coma < 1 hr or no coma 12,180 0.16% 58: Other disorders of nervous … 0.00% NEU16: Multiple Sclerosis 6,026 0.08% NEU17: Myasthenia Gravis 1,636 0.02% NEU18: Neoplasm: Central
  18. effectivehealthcare.ahrq.gov/sites/default/files/related_files/glaucoma-treatment-appendices-11-5-10-2.pdf
    October 27, 2009 - EFFECTS-PHARMACEUTICAL TREATMENTS 1 Generic Name Brand Name Adverse Reaction Ocular Cardiovascular CentralNervous System/Psychiatry Other Acetazolamide Diamox® • Transient myopia • Drowsiness, • Paresthesia … Adverse events AHRQ Agency for Health Related Quality CAI Carbonic anhidrase inhibitors CCT Central
  19. effectivehealthcare.ahrq.gov/sites/default/files/related_files/disruptive-behavior-disorders-protocol-amendment.pdf
    March 22, 2023 - nervous system stimulants - First-generation antipsychotics - Selective serotonin reuptake inhibitors … alpha-Agonists/tu, ad 15. exp Anticonvulsants/tu, ad 16. exp Adrenergic beta-Antagonists/tu, ad 17. exp CentralNervous System Stimulants/tu, ad 18. exp Antipsychotic Agents/tu, ad 19. exp Serotonin Uptake Inhibitors … (pharmacologi* or alpha agonist* or anticonvulsant* or antipsychotic* or (beta adj3 block*) or ((centralnervous system or CNS) adj3 stimulant*) or selective serotonin reuptake inhibitor* or SSRI* or (mood
  20. hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2017_Core.PDF
    January 01, 2017 - SYSTEM NEOPLASMS W MCC 20,094 0.11% 55: NERVOUS SYSTEM NEOPLASMS W/O MCC 9,671 0.05% 56: DEGENERATIVE … NERVOUS SYSTEM DISORDERS W MCC 23,262 0.13% 57: DEGENERATIVE NERVOUS SYSTEM DISORDERS W/O MCC 83,711 … OF NERVOUS SYSTEM W/O CC/MCC 17,739 0.10% 94: BACTERIAL & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM … & TUBERCULOUS INFECTIONS OF NERVOUS SYSTEM W/O CC/MCC 2,150 0.01% 97: NON-BACTERIAL INFECT OF NERVOUS … Frequency Distribution for PL_NCHS PL_NCHS Frequency Percent of Total .: Missing 90,821 0.51% 1: Large Central